Table 2. Spearman correlation analyses of serum A-FABP levels.
| Variable |
Men |
Premenopausal women |
Postmenopausal women |
|||
|---|---|---|---|---|---|---|
| r | P | r | P | r | P | |
| Body weight | 0.398 | <0.001 | 0.413 | <0.001 | 0.383 | <0.001 |
| FM | 0.448 | <0.001 | 0.470 | <0.001 | 0.432 | <0.001 |
| fat% | 0.430 | <0.001 | 0.459 | <0.001 | 0.416 | <0.001 |
| FFM | 0.268 | <0.001 | 0.199 | <0.001 | 0.195 | <0.001 |
| VFA | 0.449 | <0.001 | 0.406 | <0.001 | 0.378 | <0.001 |
| SFA | 0.415 | <0.001 | 0.362 | <0.001 | 0.283 | <0.001 |
| FPG | 0.070 | 0.047 | 0.062 | 0.147 | 0.057 | 0.154 |
| 2hPG | 0.096 | 0.007 | 0.081 | 0.059 | 0.093 | 0.019 |
| HbA1c | 0.010 | 0.789 | 0.095 | 0.027 | 0.114 | 0.004 |
| HOMA-IR | 0.362 | <0.001 | 0.266 | <0.001 | 0.290 | <0.001 |
| HOMA-β | 0.331 | <0.001 | 0.239 | <0.001 | 0.263 | <0.001 |
| TC | 0.061 | 0.087 | 0.091 | 0.034 | 0.097 | 0.015 |
| TG | 0.343 | <0.001 | 0.257 | <0.001 | 0.269 | <0.001 |
| HDL-c | –0.310 | <0.001 | –0.121 | 0.005 | –0.215 | <0.001 |
| LDL-c | 0.105 | 0.003 | 0.169 | <0.001 | 0.095 | 0.017 |
| CRP | 0.244 | <0.001 | 0.277 | <0.001 | 0.251 | <0.001 |
Abbreviations: CRP, C-reactive protein; FFM, free fat mass; FM, fat mass; fat%, fat percentage; FPG, fasting plasma glucose; HDL-c, high-density lipoprotein cholesterol; 2hPG, 2-h plasma glucose; HbA1c, glycated hemoglobin A1c; HOMA-IR, homeostasis model assessment-insulin resistance; HOMA-β, homeostasis model assessment-pancreatic β-cell secretion; LDL-c, low-density lipoprotein cholesterol; SFA, subcutaneous fat area; TC, total cholesterol; TG, triglyceride; VFA, visceral fat area.